Skip to main content
Premium Trial:

Request an Annual Quote

New York State Certifies GenetWorx to Perform Drug-Response Panel

NEW YORK (GenomeWeb) – GenetWorx said today that it has been certified by New York State to perform its drug-response genetic testing service on samples collected in the state.

The certification means Glen Allen, Va.-based GenetWorx is able to provide the test to patients in all 50 states in the US, it said. The lab is also CLIA certified.

Called the GenetWorx DNA Drug-Response Panel, the testing panel includes assays for drug metabolizing enzymes and cardiac disease risk factors. It examines a patient's genetic metabolizer type for several cytochrome 450 enzymes that activate many commonly prescribed cardiology, pain management, and psychiatry medications.

GenetWorx was founded in 2012 and provides DNA analysis for use by clinicians to support treatment decisions. In December 2013, its clinical lab received accreditation from the College of American Pathologists.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.